Dr. Landen on Molecular Subtypes of Ovarian Cancer

Video

Chip Landen, MD, associate professor, Division of Gynecologic Oncology, University of Virginia Health System, discusses the molecular subtypes of ovarian cancer.

Chip Landen, MD, associate professor, Division of Gynecologic Oncology, University of Virginia Health System, discusses the molecular subtypes of ovarian cancer.

It is important for community oncologists to understand that there are multiple subtypes of ovarian cancer. There are 2 main subtypes: epithelial and serous—the latter being the most common, Landen says. Essentially of those histologies have p53 mutations that develop early in the oncogenic process, resulting in several different genetic changes in the disease history.

Other than that, in terms of number of tumor mutations, ovarian cancer in general falls into the “moderate” category compared with other tumor types. There are very few individual genes that are frequently mutated in the majority of patients, Landen adds. BRCA1/2 are the most common genetic alterations, although they are usually germline mutations. About 7% of ovarian cancers have BRCA1/2 mutations that are somatic, meaning they occur in the tumor rather than having been inherited.

Related Videos
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD
James Knight, MD
Jason Efstathiou, MD, DPhil